Amarin Corp Plc (AMRN)

[Number sleven]

Kiwi, Duke, As soon as the generic supply issue went from theory to fact I started running thought experiments. We all know that insurance companies are not altruistic organizations concerned with providing low cost medications to better patient lives. They are interested in profit and nothing else. If an insurance company covers gv on tier 1 and V on tier 3 (standard practice when a generic is introduced). The generic supply needs to meet demand. If not insurance companies have a problem. Patients are proscribed Vascepa. They go to the local pharmacy. The pharmacy is motivated to fill the prescription with the generic. The generic is out of stock. Now the patient has a choice, leave without the needed proscription drug, or pay a much higher price for the branded product. This is going to cause insurance companies to have unsatisfied clients. How do they fix this? Cover both products on the same tier or don't cover gv at all.
This is my theory about the coverage changes.
Duke, Thanks for the DD.
Sleven,